Real-World Experience With CMV inSIGHT T Cell Immunity Testing in High-Risk Kidney and Pancreas Transplant Recipients

Cytomegalovirus antiviral stewardship in solid organ transplant recipients: A new gold standard

(2022) Margaret R Jorgenson et al.   Transplant Infectious Disease

Letermovir conversion after valganciclovir treatment in cytomegalovirus high‐risk abdominal solid organ transplant recipients may promote development of cytomegalovirus‐specific cell mediated immunity

(2021) Margaret R Jorgenson et al.   Transplant Infectious Disease

Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events

(2020) Ralph Rogers et al.   BMC INFECTIOUS DISEASES

Use of T Cell Mediated Immune Functional Assays for Adjustment of Immunosuppressive or Anti-infective Agents in Solid Organ Transplant Recipients: A Systematic Review

(2020) Omid Rezahosseini et al.   Frontiers in Immunology

The Risk of Cytomegalovirus Infection after Treatment of Acute Rejection in Renal Transplant Recipients

(2019) Margaret R Jorgenson et al.   CLINICAL TRANSPLANTATION

Can hospitalization be hazardous to your health? A nosocomial based stress model for hospitalization

(2019) Bernard P. Chang   GENERAL HOSPITAL PSYCHIATRY

Current Understanding of Cytomegalovirus Reactivation in Critical Illness

(2019) Hannah Imlay et al.   JOURNAL OF INFECTIOUS DISEASES

The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

(2018) Camille N. Kotton et al.   TRANSPLANTATION

Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis

(2018) Napat Leeaphorn et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Consistent associations between measures of psychological stress and CMV antibody levels in a large occupational sample

(2014) Jerrald L. Rector et al.   BRAIN BEHAVIOR AND IMMUNITY

Comparison of Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV Quantiferon Gamma Interferon-Releasing Assays in Assessing Risk of CMV Infection in Kidney Transplant Recipients

(2013) D. Abate et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Virus reactivation: a panoramic view in human infections

(2011) Christopher M Traylen et al.   Future Virology

Primary CMV Infections Are Common in Kidney Transplant Recipients After 6 Months Valganciclovir Prophylaxis

(2010) I. Helanterä et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

(2010) A. Humar et al.   AMERICAN JOURNAL OF TRANSPLANTATION